SCHEMBL8622245

SCHEMBL8622245

CCOP(=O)(OCC)C(CCC(Oc1ccccc1C)c1ccccc1)S(=O)(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.48
SLC6A4 P31645 5/20 0.48
CYP1A2 P05177 4/20 0.48
CYP3A4 P08684 4/20 0.48
CYP2D6 P10635 4/20 0.48
TSHR P16473 3/20 0.48
SLC6A3 Q01959 3/20 0.48
LMNA P02545 3/20 0.48
KMT2A Q03164 3/20 0.48
CHRM1 P11229 2/20 0.48
ADRA2B P18089 2/20 0.48
HTR2A P28223 2/20 0.48
HTR2C P28335 2/20 0.48
HRH1 P35367 2/20 0.48
OPRM1 P35372 2/20 0.48
DRD3 P35462 2/20 0.48
OPRK1 P41145 2/20 0.48
HTR2B P41595 2/20 0.48
KCNH2 Q12809 2/20 0.48
KLF10 Q13118 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8622280 0.86 SLC6A2 (0.52) SLC6A2SLC6A4CYP1A2CYP3A4CYP2D6
SCHEMBL8624044 0.86 POLB (0.48) SLC6A4LMNAPOLBKDM4EMAPT
SCHEMBL8621535 0.80 POLB (0.41) SLC6A4LMNAPOLBMAPTALDH1A1
SCHEMBL8623402 0.78 POLB (0.44) TSHRLMNAKMT2AALOX15POLB
SCHEMBL8624287 0.74 POLB (0.41) TSHRLMNAKMT2AALOX15POLB
SCHEMBL8626313 0.74 ACP3 (0.39) SLC6A2SLC6A4CYP1A2CYP3A4CYP2D6
SCHEMBL8618661 0.74 POLB (0.48) TSHRLMNAKMT2AALOX15POLB
SCHEMBL8619830 0.74 SLC6A2 (0.52) SLC6A2SLC6A4CYP1A2CYP3A4CYP2D6
SCHEMBL8622237 0.74 FDFT1 (0.44)
SCHEMBL8623463 0.74 ACP3 (0.34) SLC6A2SLC6A4CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed